Literature DB >> 11444579

Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

J W Cheng1, M M Kalis, S Feifer.   

Abstract

OBJECTIVES: To compare antihypertensive drug compliance with treatment guidelines established by the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI), and to identify patient adherence to antihypertensive drugs and factors affecting prescribing patterns.
METHODS: Patients filling antihypertensive drug prescriptions in metropolitan New York area pharmacies were enrolled. Pharmacy externs collected patient-reported demographics, medical and drug histories, and blood pressure measurements. Compliance with JNC VI guidelines was assessed.
RESULTS: Eight hundred twenty-one patients from 102 pharmacies participated. Blood pressure was controlled in 61% of patients at the time of the study. The most prescribed class of antihypertensive agents was angiotensin-converting enzyme inhibitors, followed by diuretics and beta-blockers. Over the study period, compliance with JNC VI guidelines decreased significantly from 85% to 64% (p<0.05). Thirty-seven percent of patients reported consistent adherence to their antihypertensive regimens. Patients' education level was the only factor found to correlate positively with the appropriateness of antihypertensive agents prescribed.
CONCLUSION: Compliance with JNC VI guidelines decreased over time, and patient adherence to drug therapy was suboptimal. Continuing-education efforts to reinforce optimal blood pressure management are necessary.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444579     DOI: 10.1592/phco.21.9.828.34557

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  14 in total

Review 1.  Medication adherence in heart failure.

Authors:  Paul J Hauptman
Journal:  Heart Fail Rev       Date:  2007-05-04       Impact factor: 4.214

2.  Impact of geographical proximity on health care seeking behaviour in northern oman.

Authors:  Ahmed Al-Mandhari; Samir Al-Adawi; Ibrahim Al-Zakwani; Mohammed Al-Shafaee; Liyam Eloul
Journal:  Sultan Qaboos Univ Med J       Date:  2008-11

3.  Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry.

Authors:  Andrew J Karter; Howard H Moffet; Jennifer Liu; Melissa M Parker; Ameena T Ahmed; Assiamira Ferrara; Joe V Selby
Journal:  Am J Manag Care       Date:  2005-04       Impact factor: 2.229

4.  Adherence to nicotine replacement patch therapy in cardiovascular patients.

Authors:  Louise C W Wiggers; Ellen M A Smets; Frans J Oort; Marja N Storm-Versloot; Hester Vermeulen; Lucas B M van Loenen; Ron J G Peters; Hanneke C J M de Haes; Dink A Legemate
Journal:  Int J Behav Med       Date:  2006

Review 5.  Hypertension and Health Behaviors in Females Across the Lifespan.

Authors:  Marie Krousel-Wood
Journal:  Am J Med Sci       Date:  2015-07       Impact factor: 2.378

6.  Relatives' advice and health care-seeking behaviour in oman.

Authors:  Ahmed Al-Mandhari; Samir Al-Adawi; Ibrahim Al-Zakwani; Mohammed Al-Shafaee; Liyam Eloul
Journal:  Sultan Qaboos Univ Med J       Date:  2009-12-19

7.  Monitoring visual status: why patients do or do not comply with practice guidelines.

Authors:  Frank A Sloan; Derek S Brown; Emily Streyer Carlisle; Gabriel A Picone; Paul P Lee
Journal:  Health Serv Res       Date:  2004-10       Impact factor: 3.402

Review 8.  Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence.

Authors:  Janet B McGill
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

9.  Exploring patients' reasons for discontinuance of heart medications.

Authors:  Linda Garavalia; Brian Garavalia; John A Spertus; Carole Decker
Journal:  J Cardiovasc Nurs       Date:  2009 Sep-Oct       Impact factor: 2.083

10.  Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes.

Authors:  Yaman Kassab; Yahaya Hassan; Noorizan Abd Aziz; Omar Ismail; Hadeer AbdulRazzaq
Journal:  Int J Clin Pharm       Date:  2013-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.